Late last year, in AstraZeneca v. Aurobindo (In re Rosuvastatin Calcium Patent Litigation), the Federal Circuit affirmed that a reissue patent covering the active ingredient of Crestor® was valid, ...
Data presented at this year’s AHA reinforces the established efficacy profile of CRESTOR (rosuvastatin) Treatment with CRESTOR (rosuvastatin) or atorvastatin for two years resulted in statistically ...
Nov 10 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd : * Says its Changzhou-based unit's Rosuvastatin Calcium Tablets (5mg/10mg/20mg/40mg) were approved by U.S Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results